Other Species / Isoforms
  NME1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
R6-m1
__MANCErTFIAIkP
0 1
NME1 (human) __MANCErTFIAIkP R6-m1
NME1 iso2 (human) GTMANCERTFIAIKP R31
NME1 (mouse) __MANSERTFIAIkP R6
NME1 (rat) __MANSERTFIAIkP R6
K12-ac
ErTFIAIkPDGVQRG
0 4
NME1 (human) ErTFIAIkPDGVQRG K12-ac
NME1 iso2 (human) ERTFIAIKPDGVQRG K37
NME1 (mouse) ERTFIAIKPDGVQRG K12
NME1 (rat) ERTFIAIkPDGVQRG K12-ac
K12-ub
ErTFIAIkPDGVQRG
0 113
NME1 (human) ErTFIAIkPDGVQRG K12-ub
NME1 iso2 (human) ERTFIAIKPDGVQRG K37
NME1 (mouse) ERTFIAIkPDGVQRG K12-ub
NME1 (rat) ERTFIAIkPDGVQRG K12-ub
K26-ac
GLVGEIIkRFEQkGF
0 6
NME1 (human) GLVGEIIkRFEQkGF K26-ac
NME1 iso2 (human) GLVGEIIKRFEQKGF K51
NME1 (mouse) GLVGEIIkRFEQkGF K26-ac
NME1 (rat) GLVGEIIkRFEQkGF K26-ac
K26-ub
GLVGEIIkRFEQkGF
0 8
NME1 (human) GLVGEIIkRFEQkGF K26-ub
NME1 iso2 (human) GLVGEIIKRFEQKGF K51
NME1 (mouse) GLVGEIIkRFEQkGF K26-ub
NME1 (rat) GLVGEIIKRFEQkGF K26
K31-ac
IIkRFEQkGFRLVGL
0 5
NME1 (human) IIkRFEQkGFRLVGL K31-ac
NME1 iso2 (human) IIKRFEQKGFRLVGL K56
NME1 (mouse) IIkRFEQkGFRLVGL K31-ac
NME1 (rat) IIkRFEQkGFRLVGL K31-ac
K39-ub
GFRLVGLkFMQAsED
0 2
NME1 (human) GFRLVGLkFMQAsED K39-ub
NME1 iso2 (human) GFRLVGLKFMQASED K64
NME1 (mouse) GFRLVGLkFLQASED K39-ub
NME1 (rat) GFRLVGLKFIQASED K39
S44-p
GLkFMQAsEDLLkEH
Upstream
Downstream
4 2
Effects on Biological Processes:
  • cell growth, altered
Kinase, in vitro:
  • NME1 (human)
Treatment
  • colforsin
NME1 (human) GLkFMQAsEDLLkEH S44-p
NME1 iso2 (human) GLKFMQASEDLLKEH S69
NME1 (mouse) GLkFLQASEDLLkEH S44
NME1 (rat) GLKFIQASEDLLkEH S44
K49-ac
QAsEDLLkEHyVDLk
0 5
NME1 (human) QAsEDLLkEHyVDLk K49-ac
NME1 iso2 (human) QASEDLLKEHYVDLK K74
NME1 (mouse) QASEDLLkEHYTDLk K49-ac
NME1 (rat) QASEDLLkEHYIDLk K49-ac
K49-ub
QAsEDLLkEHyVDLk
0 11
NME1 (human) QAsEDLLkEHyVDLk K49-ub
NME1 iso2 (human) QASEDLLKEHYVDLK K74
NME1 (mouse) QASEDLLkEHYTDLk K49-ub
NME1 (rat) QASEDLLKEHYIDLk K49
Y52-p
EDLLkEHyVDLkDrP
0 10
NME1 (human) EDLLkEHyVDLkDrP Y52-p
NME1 iso2 (human) EDLLKEHYVDLKDRP Y77
NME1 (mouse) EDLLkEHYTDLkDRP Y52
NME1 (rat) EDLLkEHYIDLkDRP Y52
K56-ac
kEHyVDLkDrPFFAG
1 4
NME1 (human) kEHyVDLkDrPFFAG K56-ac
NME1 iso2 (human) KEHYVDLKDRPFFAG K81
NME1 (mouse) kEHYTDLkDRPFFTG K56-ac
NME1 (rat) kEHYIDLkDRPFFSG K56-ac
K56-ub
kEHyVDLkDrPFFAG
Upstream
0 70
Treatment
  • MG132
NME1 (human) kEHyVDLkDrPFFAG K56-ub
NME1 iso2 (human) KEHYVDLKDRPFFAG K81
NME1 (mouse) kEHYTDLkDRPFFTG K56-ub
NME1 (rat) kEHYIDLkDRPFFSG K56-ub
K56-sc
kEHyVDLkDrPFFAG
0 1
NME1 (human) kEHyVDLkDrPFFAG K56-sc
NME1 iso2 (human) KEHYVDLKDRPFFAG K81
NME1 (mouse) kEHYTDLKDRPFFTG K56
NME1 (rat) kEHYIDLKDRPFFSG K56
R58-m1
HyVDLkDrPFFAGLV
0 1
NME1 (human) HyVDLkDrPFFAGLV R58-m1
NME1 iso2 (human) HYVDLKDRPFFAGLV R83
NME1 (mouse) HYTDLkDRPFFTGLV R58
NME1 (rat) HYIDLkDRPFFSGLV R58
K66-ac
PFFAGLVkyMHSGPV
0 2
NME1 (human) PFFAGLVkyMHSGPV K66-ac
NME1 iso2 (human) PFFAGLVKYMHSGPV K91
NME1 (mouse) PFFTGLVKYMHSGPV K66
NME1 (rat) PFFSGLVKYMHSGPV K66
K66-ub
PFFAGLVkyMHSGPV
0 12
NME1 (human) PFFAGLVkyMHSGPV K66-ub
NME1 iso2 (human) PFFAGLVKYMHSGPV K91
NME1 (mouse) PFFTGLVKYMHSGPV K66
NME1 (rat) PFFSGLVKYMHSGPV K66
Y67-p
FFAGLVkyMHSGPVV
0 1
NME1 (human) FFAGLVkyMHSGPVV Y67-p
NME1 iso2 (human) FFAGLVKYMHSGPVV Y92
NME1 (mouse) FFTGLVKYMHSGPVV Y67
NME1 (rat) FFSGLVKYMHSGPVV Y67
K85-ac
WEGLNVVkTGRVMLG
0 1
NME1 (human) WEGLNVVkTGRVMLG K85-ac
NME1 iso2 (human) WEGLNVVKTGRVMLG K110
NME1 (mouse) WEGLNVVKTGRVMLG K85
NME1 (rat) WEGLNVVKTGRVMLG K85
K85-ub
WEGLNVVkTGRVMLG
1 2
NME1 (human) WEGLNVVkTGRVMLG K85-ub
NME1 iso2 (human) WEGLNVVKTGRVMLG K110
NME1 (mouse) WEGLNVVKTGRVMLG K85
NME1 (rat) WEGLNVVKTGRVMLG K85
T94-p
GRVMLGEtNPADskP
Upstream
0 56
Kinase, in vitro:
  • CDK1 (human)
Treatment
  • anti-CD3
  • EGF
  • nocodazole
NME1 (human) GRVMLGEtNPADskP T94-p
NME1 iso2 (human) GRVMLGETNPADSKP T119
NME1 (mouse) GRVMLGEtNPADskP T94-p
NME1 (rat) GRVMLGEtNPADskP T94-p
S99-p
GEtNPADskPGTIRG
0 22
NME1 (human) GEtNPADskPGTIRG S99-p
NME1 iso2 (human) GETNPADSKPGTIRG S124
NME1 (mouse) GEtNPADskPGTIRG S99-p
NME1 (rat) GEtNPADskPGTIRG S99-p
K100-ac
EtNPADskPGTIRGD
0 15
NME1 (human) EtNPADskPGTIRGD K100-ac
NME1 iso2 (human) ETNPADSKPGTIRGD K125
NME1 (mouse) EtNPADskPGTIRGD K100-ac
NME1 (rat) EtNPADskPGTIRGD K100-ac
K100-ub
EtNPADskPGTIRGD
0 103
NME1 (human) EtNPADskPGTIRGD K100-ub
NME1 iso2 (human) ETNPADSKPGTIRGD K125
NME1 (mouse) EtNPADskPGTIRGD K100-ub
NME1 (rat) EtNPADsKPGTIRGD K100
H118-p
QVGRNIIhGsDsVEs
Upstream
5 1
Kinase, in vitro:
  • NME1 (human)
Putative in vivo kinases:
  • NME1 (human)
NME1 (human) QVGRNIIhGsDsVEs H118-p
NME1 iso2 (human) QVGRNIIHGSDSVES H143
NME1 (mouse) QVGRNIIHGsDsVks H118
NME1 (rat) QVGRNIIHGsDSVEs H118
S120-p
GRNIIhGsDsVEsAE
Upstream
Downstream
5 20
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
  • protein conformation
Effects on Biological Processes:
  • cell growth, altered
Kinase, in vitro:
  • CDK1 (human)
  • NME1 (human)
Treatment
  • dasatinib
NME1 (human) GRNIIhGsDsVEsAE S120-p
NME1 iso2 (human) GRNIIHGSDSVESAE S145
NME1 (mouse) GRNIIHGsDsVksAE S120-p
NME1 (rat) GRNIIHGsDSVEsAE S120-p
S122-p
NIIhGsDsVEsAEKE
1 15
NME1 (human) NIIhGsDsVEsAEKE S122-p
NME1 iso2 (human) NIIHGSDSVESAEKE S147
NME1 (mouse) NIIHGsDsVksAEkE S122-p
NME1 (rat) NIIHGsDSVEsAEkE S122
E124
IhGsDsVEsAEKEIG
0 2
NME1 (human) IhGsDsVEsAEKEIG E124
NME1 iso2 (human) IHGSDSVESAEKEIG E149
NME1 (mouse) IHGsDsVksAEkEIS K124-ac
NME1 (rat) IHGsDSVEsAEkEIS E124
E124
IhGsDsVEsAEKEIG
0 11
NME1 (human) IhGsDsVEsAEKEIG E124
NME1 iso2 (human) IHGSDSVESAEKEIG E149
NME1 (mouse) IHGsDsVksAEkEIS K124-ub
NME1 (rat) IHGsDSVEsAEkEIS E124
E124
IhGsDsVEsAEKEIG
0 1
NME1 (human) IhGsDsVEsAEKEIG E124
NME1 iso2 (human) IHGSDSVESAEKEIG E149
NME1 (mouse) IHGsDsVksAEkEIS K124-sc
NME1 (rat) IHGsDSVEsAEkEIS E124
S125-p
hGsDsVEsAEKEIGL
0 7
NME1 (human) hGsDsVEsAEKEIGL S125-p
NME1 iso2 (human) HGSDSVESAEKEIGL S150
NME1 (mouse) HGsDsVksAEkEISL S125-p
NME1 (rat) HGsDSVEsAEkEISL S125-p
K128
DsVEsAEKEIGLWFH
0 1
NME1 (human) DsVEsAEKEIGLWFH K128
NME1 iso2 (human) DSVESAEKEIGLWFH K153
NME1 (mouse) DsVksAEkEISLWFQ K128-ac
NME1 (rat) DSVEsAEKEISLWFQ K128
K128
DsVEsAEKEIGLWFH
0 3
NME1 (human) DsVEsAEKEIGLWFH K128
NME1 iso2 (human) DSVESAEKEIGLWFH K153
NME1 (mouse) DsVksAEkEISLWFQ K128-ub
NME1 (rat) DSVEsAEkEISLWFQ K128-ub
Y151
SCAQNWIYE______
0 1
NME1 (human) SCAQNWIYE______ Y151
NME1 iso2 (human) SCAQNWIYE______ Y176
NME1 (mouse) SCAQNWIyE______ Y151-p
NME1 (rat) SCAQNWIYE______ Y151